|
Quotes & Info
|
| AMRN > SEC Filings for AMRN > Form 8-K on 27-Jul-2012 | All Recent SEC Filings |
27-Jul-2012
Other Events, Financial Statements and Exhibits
On July 26, 2012, Amarin Corporation plc issued a press release titled, "Amarin Announces FDA Approval of VascepaTM (icosapent ethyl) Capsules for the Reduction of Triglyceride Levels in Adult Patients with Severe (TG>500mg/dL) Hypertriglyceridemia."
A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
(d) Exhibits.
Exhibit No. Description
99.1 Press Release dated July 26, 2012.
|
|